Reuters logo
a year ago
BRIEF-Respiratorius: EMA recommends European Orphan Drug Designation for VAL001
October 7, 2016 / 11:42 AM / a year ago

BRIEF-Respiratorius: EMA recommends European Orphan Drug Designation for VAL001

Oct 7 (Reuters) - Respiratorius AB (publ) :

* The European Medicines Agency's Committee for Orphan Drugs in Europe (the Committee for Orphan Medicinal Products - COMP) has informed Respiratorius of a positive decision regarding Respiratorius application for VAL001 to obtain Orphan Drug Designation in Europe

Source text: bit.ly/2dxwT5M

Further company coverage:

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below